Nuzenio

Targeting Adc Zocilurtatug

Targeting Adc Zocilurtatug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Nieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - OncodailyOncodaily · Fri, 07 Aug 2026 11:52:07 GMTZai Lab (NASDAQ: ZLAB) posts Q2 2026 net loss of $50.8M - Stock TitanStock Titan · Thu, 06 Aug 2026 10:35:01 GMTZai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates - Business WireBusiness Wire · Thu, 06 Aug 2026 10:30:00 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSciAllSci · Tue, 04 Aug 2026 12:20:33 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLiveOncLive · Mon, 03 Aug 2026 15:59:22 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMT

Timeline

Fri, 07 Aug 2026 11:52:07 GMTNieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - Oncodaily
Thu, 06 Aug 2026 10:35:01 GMTZai Lab (NASDAQ: ZLAB) posts Q2 2026 net loss of $50.8M - Stock Titan
Thu, 06 Aug 2026 10:30:00 GMTZai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates - Business Wire
Tue, 04 Aug 2026 12:20:33 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSci
Mon, 03 Aug 2026 15:59:22 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLive
Mon, 03 Aug 2026 11:00:00 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Targeting Adc Zocilurtatug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.